Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Kris A. Manlove-Simmons, M.D.
FDA Inspection
•Kris A. Manlove-Simmons, M.D.•August 30, 2011

Kris A. Manlove-Simmons, M.D. – FDA Inspection, Aug 30, 2011

Record Details

This FDA Inspection record concerns Kris A. Manlove-Simmons, M.D., with an inspection on August 30, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Kris A. Manlove-Simmons, M.D.
Inspection Date
August 30, 2011
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 3ffc195f-3654-468d-94d6-890fff3ecc69

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
660506
FDA center
Human Drugs
Project area
Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kris A. Manlove-Simmons, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.